Showing results (61-70 of 689) with videos related to

Sort By:
Pageof 69
Lancet (London, England)|January 17, 2026
Glucagon-like receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefitsMichael A Nauck, Katherine R Tuttle, Matthias H Tschöp, et al.
European Journal of Pharmacology|May 15, 2002
Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectivesJuris J Meier, Baptist Gallwitz, Wolfgang E Schmidt, et al.
Diabetes|March 25, 2011
Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humansMichael A Nauck, Guido Kemmeries, Jens J Holst, et al.
Molecular Metabolism|October 17, 2020
GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-artMichael A Nauck, Daniel R Quast, Jakob Wefers, et al.
Diabetes, Obesity & Metabolism|March 19, 2026
Challenging the Consensus Statement: Is It Time to Recognise Pharmacological Remission of Type 2 Diabetes?Cristina Bianchi, Stefano Del Prato, Amy E Rothberg, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|October 15, 2005
New management approaches for gastroparesisChristopher K Rayner, Michael Horowitz
The Journal of Clinical Investigation|February 3, 2006
Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited?Christopher K Rayner, Michael Horowitz
Pageof 69